{"pmid":32427517,"title":"COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.","text":["COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.","The successful sequencing of the novel coronavirus SARS-CoV-2 nucleic acid paved the way for exploration of omics systems science and integrative biology research approaches for combating this unprecedented planetary health challenge. Omics-scale studies on this viral infection are emerging rapidly and offer a tremendous potential to unravel the puzzles of the SARS-CoV-2 pathobiology, and ways forward for diagnostic and therapeutic innovation.","OMICS","Ray, Sandipan","Srivastava, Sanjeeva","32427517"],"abstract":["The successful sequencing of the novel coronavirus SARS-CoV-2 nucleic acid paved the way for exploration of omics systems science and integrative biology research approaches for combating this unprecedented planetary health challenge. Omics-scale studies on this viral infection are emerging rapidly and offer a tremendous potential to unravel the puzzles of the SARS-CoV-2 pathobiology, and ways forward for diagnostic and therapeutic innovation."],"journal":"OMICS","authors":["Ray, Sandipan","Srivastava, Sanjeeva"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427517","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1089/omi.2020.0073","keywords":["covid-19","omics","sars-cov-2","systems biology"],"weight":0,"_version_":1667352728796397570,"score":9.490897,"similar":[{"pmid":32329102,"title":"Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment.","text":["Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment.","The ongoing outbreak of the novel coronavirus (SARS-CoV-2) infection is creating serious challenges for health laboratories that seek to identify viral infections as early as possible, optimally at the earliest appearance of symptom. Indeed, there is urgent need to develop and deploy robust diagnostic methodologies not only to use in health laboratory environments but also directly in places where humans circulate and spread the virus such as airports, trains, boats, and any public aggregation places. The success of a reliable and sensitive asymptomatic diagnosis relies on the identification and measurement of informative biomarkers from human host and virus in a rapid, sensitive, and inexpensive manner. The objective of this article is to describe an innovative multidisciplinary approach to develop an efficient, inexpensive, and easy-to-use portable instrument (bCUBE((R)) by Hyris Ltd) that can be employed as a surveillance system for the emergency caused by SARS-CoV-2. A solution for Coronavirus testing, compliant with CDC guidelines, is scheduled to be released in the next weeks. In addition, we will describe a workflow and path of an integrated multi-omic approach that will lead to host and pathogen biomarker discovery in order to train the instrument to provide reliable results based on a specific biomarker's fingerprint of SARS-CoV-2 infection.","Immunol Rev","Martinelli, Federico","Perrone, Anna","Della Noce, Isabella","Colombo, Lorenzo","Lo Priore, Stefano","Romano, Simone","32329102"],"abstract":["The ongoing outbreak of the novel coronavirus (SARS-CoV-2) infection is creating serious challenges for health laboratories that seek to identify viral infections as early as possible, optimally at the earliest appearance of symptom. Indeed, there is urgent need to develop and deploy robust diagnostic methodologies not only to use in health laboratory environments but also directly in places where humans circulate and spread the virus such as airports, trains, boats, and any public aggregation places. The success of a reliable and sensitive asymptomatic diagnosis relies on the identification and measurement of informative biomarkers from human host and virus in a rapid, sensitive, and inexpensive manner. The objective of this article is to describe an innovative multidisciplinary approach to develop an efficient, inexpensive, and easy-to-use portable instrument (bCUBE((R)) by Hyris Ltd) that can be employed as a surveillance system for the emergency caused by SARS-CoV-2. A solution for Coronavirus testing, compliant with CDC guidelines, is scheduled to be released in the next weeks. In addition, we will describe a workflow and path of an integrated multi-omic approach that will lead to host and pathogen biomarker discovery in order to train the instrument to provide reliable results based on a specific biomarker's fingerprint of SARS-CoV-2 infection."],"journal":"Immunol Rev","authors":["Martinelli, Federico","Perrone, Anna","Della Noce, Isabella","Colombo, Lorenzo","Lo Priore, Stefano","Romano, Simone"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329102","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/imr.12857","keywords":["sars-cov-2 detection","coronavirus","device","instrument","portable"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494664179712,"score":120.401794},{"pmid":32452701,"title":"An up-to-date overview of computational polypharmacology in modern drug discovery.","text":["An up-to-date overview of computational polypharmacology in modern drug discovery.","INTRODUCTION: In recent years, computational polypharmacology has gained significant attention to study the promiscuous nature of drugs. Despite tremendous challenges, community-wide efforts have led to a variety of novel approaches for predicting drug polypharmacology. In particular, some rapid advances using machine learning and artificial intelligence have been reported with great success. AREAS COVERED: In this article, the authors provide a comprehensive update on the current state-of-the-art polypharmacology approaches and their applications, focusing on those reports published after our 2017 review article. The authors particularly discuss some novel, groundbreaking concepts, and methods that have been developed recently and applied to drug polypharmacology studies. EXPERT OPINION: Polypharmacology is evolving and novel concepts are being introduced to counter the current challenges in the field. However, major hurdles remain including incompleteness of high-quality experimental data, lack of in vitro and in vivo assays to characterize multi-targeting agents, shortage of robust computational methods, and challenges to identify the best target combinations and design effective multi-targeting agents. Fortunately, numerous national/international efforts including multi-omics and artificial intelligence initiatives as well as most recent collaborations on addressing the COVID-19 pandemic have shown significant promise to propel the field of polypharmacology forward.","Expert Opin Drug Discov","Chaudhari, Rajan","Fong, Long Wolf","Tan, Zhi","Huang, Beibei","Zhang, Shuxing","32452701"],"abstract":["INTRODUCTION: In recent years, computational polypharmacology has gained significant attention to study the promiscuous nature of drugs. Despite tremendous challenges, community-wide efforts have led to a variety of novel approaches for predicting drug polypharmacology. In particular, some rapid advances using machine learning and artificial intelligence have been reported with great success. AREAS COVERED: In this article, the authors provide a comprehensive update on the current state-of-the-art polypharmacology approaches and their applications, focusing on those reports published after our 2017 review article. The authors particularly discuss some novel, groundbreaking concepts, and methods that have been developed recently and applied to drug polypharmacology studies. EXPERT OPINION: Polypharmacology is evolving and novel concepts are being introduced to counter the current challenges in the field. However, major hurdles remain including incompleteness of high-quality experimental data, lack of in vitro and in vivo assays to characterize multi-targeting agents, shortage of robust computational methods, and challenges to identify the best target combinations and design effective multi-targeting agents. Fortunately, numerous national/international efforts including multi-omics and artificial intelligence initiatives as well as most recent collaborations on addressing the COVID-19 pandemic have shown significant promise to propel the field of polypharmacology forward."],"journal":"Expert Opin Drug Discov","authors":["Chaudhari, Rajan","Fong, Long Wolf","Tan, Zhi","Huang, Beibei","Zhang, Shuxing"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452701","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1080/17460441.2020.1767063","keywords":["drug polypharmacology","artificial intelligence","deep learning","drug repurposing","molecular promiscuity","multi-omics","multi-targeting design","network pharmacology","off-targets"],"topics":["Treatment"],"weight":1,"_version_":1667881798576635904,"score":107.52686},{"pmid":32397688,"title":"SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions.","text":["SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions.","The COVID-19 pandemic is due to infection caused by the novel SARS-CoV-2 virus that impacts the lower respiratory tract. The spectrum of symptoms ranges from asymptomatic infections to mild respiratory symptoms to the lethal form of COVID-19 which is associated with severe pneumonia, acute respiratory distress, and fatality. To address this global crisis, up-to-date information on viral genomics and transcriptomics is crucial for understanding the origins and global dispersion of the virus, providing insights into viral pathogenicity, transmission, and epidemiology, and enabling strategies for therapeutic interventions, drug discovery, and vaccine development. Therefore, this review provides a comprehensive overview of COVID-19 epidemiology, genomic etiology, findings from recent transcriptomic map analysis, viral-human protein interactions, molecular diagnostics, and the current status of vaccine and novel therapeutic intervention development. Moreover, we provide an extensive list of resources that will help the scientific community access numerous types of databases related to SARS-CoV-2 OMICs and approaches to therapeutics related to COVID-19 treatment.","Viruses","Uddin, Mohammed","Mustafa, Farah","Rizvi, Tahir A","Loney, Tom","Suwaidi, Hanan Al","Al-Marzouqi, Ahmed H Hassan","Eldin, Afaf Kamal","Alsabeeha, Nabeel","Adrian, Thomas E","Stefanini, Cesare","Nowotny, Norbert","Alsheikh-Ali, Alawi","Senok, Abiola C","32397688"],"abstract":["The COVID-19 pandemic is due to infection caused by the novel SARS-CoV-2 virus that impacts the lower respiratory tract. The spectrum of symptoms ranges from asymptomatic infections to mild respiratory symptoms to the lethal form of COVID-19 which is associated with severe pneumonia, acute respiratory distress, and fatality. To address this global crisis, up-to-date information on viral genomics and transcriptomics is crucial for understanding the origins and global dispersion of the virus, providing insights into viral pathogenicity, transmission, and epidemiology, and enabling strategies for therapeutic interventions, drug discovery, and vaccine development. Therefore, this review provides a comprehensive overview of COVID-19 epidemiology, genomic etiology, findings from recent transcriptomic map analysis, viral-human protein interactions, molecular diagnostics, and the current status of vaccine and novel therapeutic intervention development. Moreover, we provide an extensive list of resources that will help the scientific community access numerous types of databases related to SARS-CoV-2 OMICs and approaches to therapeutics related to COVID-19 treatment."],"journal":"Viruses","authors":["Uddin, Mohammed","Mustafa, Farah","Rizvi, Tahir A","Loney, Tom","Suwaidi, Hanan Al","Al-Marzouqi, Ahmed H Hassan","Eldin, Afaf Kamal","Alsabeeha, Nabeel","Adrian, Thomas E","Stefanini, Cesare","Nowotny, Norbert","Alsheikh-Ali, Alawi","Senok, Abiola C"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32397688","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3390/v12050526","keywords":["covid-19","sars-cov-2","coronavirus","pandemic","viral genomics"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666714494705860608,"score":92.80993},{"pmid":32324451,"title":"Do Not Forget Afghanistan in Times of COVID-19: Telemedicine and the Internet of Things to Strengthen Planetary Health Systems.","text":["Do Not Forget Afghanistan in Times of COVID-19: Telemedicine and the Internet of Things to Strengthen Planetary Health Systems.","Health care does not always take place in a setting of peace, prosperity, and social order, a point that is often overlooked in quotidian medical practice. This has become most evident with the current COVID-19 pandemic by the new coronavirus that is wreaking havoc across the planet. Health care providers are facing unprecedented challenges to intervene on numerous nonlinear uncertainties in science and society as the pandemic evolves. In Afghanistan, health care delivery is already a major crosscutting challenge. Although efforts to rebuild the health care systems in Afghanistan have been made (Acerra et al.), both acute and chronic illnesses remain as major medical and critical governance gaps to be remedied. In addition, health care facilities and medical equipment are not adequate in the country. There is a need for medical and scientific expertise to clinically and sociologically contextualize and interpret diagnostic tests as well as drugs and vaccines that will be deployed in the coming months as part of the planetary collective response to the COVID-19 pandemic. In a time of pandemic and facing a novel infectious pathogen, health care workers are in need of planetary scale consultation and support. Even creating a small consultation network using mobile applications might offer improved health outcomes. The Internet of Things and digital health ought to be considered in concert with telemedicine as part of an effective pandemic response.","OMICS","Azizy, Abdulmunir","Fayaz, Mujtaba","Agirbasli, Mehmet","32324451"],"abstract":["Health care does not always take place in a setting of peace, prosperity, and social order, a point that is often overlooked in quotidian medical practice. This has become most evident with the current COVID-19 pandemic by the new coronavirus that is wreaking havoc across the planet. Health care providers are facing unprecedented challenges to intervene on numerous nonlinear uncertainties in science and society as the pandemic evolves. In Afghanistan, health care delivery is already a major crosscutting challenge. Although efforts to rebuild the health care systems in Afghanistan have been made (Acerra et al.), both acute and chronic illnesses remain as major medical and critical governance gaps to be remedied. In addition, health care facilities and medical equipment are not adequate in the country. There is a need for medical and scientific expertise to clinically and sociologically contextualize and interpret diagnostic tests as well as drugs and vaccines that will be deployed in the coming months as part of the planetary collective response to the COVID-19 pandemic. In a time of pandemic and facing a novel infectious pathogen, health care workers are in need of planetary scale consultation and support. Even creating a small consultation network using mobile applications might offer improved health outcomes. The Internet of Things and digital health ought to be considered in concert with telemedicine as part of an effective pandemic response."],"journal":"OMICS","authors":["Azizy, Abdulmunir","Fayaz, Mujtaba","Agirbasli, Mehmet"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324451","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1089/omi.2020.0053","keywords":["afghanistan","covid-19","internet of things","pandemic","planetary health","telemedicine"],"locations":["quotidian","Afghanistan","Afghanistan","Afghanistan"],"countries":["Afghanistan"],"countries_codes":["AFG|Afghanistan"],"topics":["Prevention"],"weight":1,"_version_":1666138493871456256,"score":90.400185},{"pmid":32502733,"title":"Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach.","text":["Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach.","The newly identified SARS-CoV-2 has now been reported from around 185 countries with more than a million confirmed human cases including more than 120,000 deaths. The genomes of SARS-COV-2 strains isolated from different parts of the world are now available and the unique features of constituent genes and proteins need to be explored to understand the biology of the virus. Spike glycoprotein is one of the major targets to be explored because of its role during the entry of coronaviruses into host cells. We analyzed 320 whole-genome sequences and 320 spike protein sequences of SARS-CoV-2 using multiple sequence alignment. In this study, 483 unique variations have been identified among the genomes of SARS-CoV-2 including 25 nonsynonymous mutations and one deletion in the spike (S) protein. Among the 26 variations detected, 12 variations were located at the N-terminal domain and 6 variations at the receptor-binding domain (RBD) which might alter the interaction of S protein with the host receptor angiotensin converting enzyme-2 (ACE2). Besides, 22 amino acid insertions were identified in the spike protein of SARS-CoV-2 in comparison with that of SARS-CoV. Phylogenetic analyses of spike protein revealed that Bat coronavirus have a close evolutionary relationship with circulating SARS-CoV-2. The genetic variation analysis data presented in this study can help a better understanding of SARS-CoV-2 pathogenesis. Based on results reported herein, potential inhibitors against S protein can be designed by considering these variations and their impact on protein structure.","Infect Genet Evol","Lokman, Syed Mohammad","Rasheduzzaman, M D","Salauddin, Asma","Barua, Rocktim","Tanzina, Afsana Yeasmin","Rumi, Meheadi Hasan","Hossain, M D Imran","Siddiki, A M A M Zonaed","Mannan, Adnan","Hasan, M D Mahbub","32502733"],"abstract":["The newly identified SARS-CoV-2 has now been reported from around 185 countries with more than a million confirmed human cases including more than 120,000 deaths. The genomes of SARS-COV-2 strains isolated from different parts of the world are now available and the unique features of constituent genes and proteins need to be explored to understand the biology of the virus. Spike glycoprotein is one of the major targets to be explored because of its role during the entry of coronaviruses into host cells. We analyzed 320 whole-genome sequences and 320 spike protein sequences of SARS-CoV-2 using multiple sequence alignment. In this study, 483 unique variations have been identified among the genomes of SARS-CoV-2 including 25 nonsynonymous mutations and one deletion in the spike (S) protein. Among the 26 variations detected, 12 variations were located at the N-terminal domain and 6 variations at the receptor-binding domain (RBD) which might alter the interaction of S protein with the host receptor angiotensin converting enzyme-2 (ACE2). Besides, 22 amino acid insertions were identified in the spike protein of SARS-CoV-2 in comparison with that of SARS-CoV. Phylogenetic analyses of spike protein revealed that Bat coronavirus have a close evolutionary relationship with circulating SARS-CoV-2. The genetic variation analysis data presented in this study can help a better understanding of SARS-CoV-2 pathogenesis. Based on results reported herein, potential inhibitors against S protein can be designed by considering these variations and their impact on protein structure."],"journal":"Infect Genet Evol","authors":["Lokman, Syed Mohammad","Rasheduzzaman, M D","Salauddin, Asma","Barua, Rocktim","Tanzina, Afsana Yeasmin","Rumi, Meheadi Hasan","Hossain, M D Imran","Siddiki, A M A M Zonaed","Mannan, Adnan","Hasan, M D Mahbub"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502733","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.meegid.2020.104389","keywords":["covid-19","genomic variants","sars-cov-2","sequence analysis","spike protein"],"locations":["Phylogenetic"],"topics":["Mechanism"],"weight":1,"_version_":1668804508815196160,"score":87.31151}]}